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Abstract
Objectives: The aim of this critical review was to evaluate whether commonly used 
biologic diagnostic parameters correspond to implant survival and peri‐implantitis 
prevalence.
Materials and methods: Publications from 2011 to 2017 were selected by an electronic 
search using the Pubmed database of the US National Library of Medicine. Prospective 
and retrospective studies with a mean follow‐up time of at least 5 years and reporting 
prevalence of peri‐implantitis as well as mean bone loss and standard deviation were 
selected. The correlation between reported prevalence of peri‐implantitis and reported 
implant survival, mean follow‐up time, mean bone loss, mean probing depth, and mean 
bleeding on probing was calculated. Mean bone loss and standard deviation were used 
for estimation of proportion of implants with bone loss exceeding 1, 2, and 3 mm.
Results: Full‐text analysis was performed for 255 papers from 4,173 available ones, and 
41 met all the inclusion criteria. The overall mean weighted survival rate was 96.9% 
(89.9%–100%) and the reported prevalence of peri‐implantitis ranged between 0% and 
39.7%, based on 15 different case definitions. The overall weighted bone loss was 1.1 mm 
based on 8,182 implants and an average mean loading time ranging from 5 to 20 years. 
No correlation was found between mean bone loss and the reported prevalence of peri‐
implantitis. The estimated prevalence of implants with bone loss above 2 mm was 23%. 
The overall weighted mean probing depth was 3.3 mm, and mean weighted bleeding was 
52.2%. Only a weak correlation was found between survival and function time (r = −0.49). 
There was no relation between the probing depth or bleeding and the mean bone loss, 
mean follow‐up time, and reported prevalence of peri‐implantitis.
Conclusion: Biologic parameters mean probing depth and mean bleeding on probing 
do not correlate with mean bone loss and this irrespective of follow‐up. Case defini‐
tion for peri‐implantitis varied significantly between studies indicating that an unam‐
biguous definition based on a specified threshold for bone loss is not agreed upon in 
the literature.
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1  | INTRODUC TION
Dental implants are widely used to restore partial and full edentu‐
lism. Due to a continuous improvement of implant designs, implant 
surface topographies, and prosthetic components, implant dentistry 
today yields excellent long‐term results in terms of implant survival. 
Doornewaard et al. (2017) performed a systematic review including 
papers with above 5‐year follow‐up yielding a 97.3% weighted im‐
plant survival rate. Numerous clinical studies with a 10‐year follow‐
up yield survival rates of over 95% (Buser et al., 2012; Degidi, Nardi 
& Piattelli, 2012; Fischer & Stenberg, 2012; Gotfredsen, 2012; Jemt, 
2017). For single tooth replacements on turned implants, cumulative 
survival rates of 96.8% after 17–19 years (Bergenblock, Andersson, 
Furst & Jemt, 2012) and 91.5% after 16–22 years (Dierens, 
Vandeweghe, Kisch, Nilner & De Bruyn, 2012) were reported. In fully 
edentulous jaws, a 97% implant survival after on average 14 years 
has been reported (Vandeweghe, Ferreira, Vermeersch, Marien & De 
Bruyn, 2016). Up to 20 years, implant survival rates in the range of 
80%–95% have been reported with turned implants in fully eden‐
tulous jaws (Astrand, Ahlqvist, Gunne & Nilson, 2008; Attard & 
Zarb, 2004; Ekelund, Lindquist, Carlsson & Jemt, 2003; Lindquist, 
Carlsson & Jemt, 1996). Chappuis et al. (2013) reported in a pro‐
spective study 89.5% survival of titanium plasma‐sprayed implants 
after 20 years of function in partially edentulous cases. Compared 
with the era of introduction of dental implants in clinical practice 
half a century ago, implant survival is today predictable, regardless 
of implant length, implant diameter, bone quality, available bone vol‐
ume, surgical, or prosthetic treatment protocol (Buser, Sennerby & 
De Bruyn, 2017). Apart from restoring function and esthetics, this 
has also affected patient‐reported quality of life (De Bruyn, Raes, 
Matthys & Cosyn, 2015).
This positivity has over the last decade been affected by the 
escalating discussion on peri‐implantitis, which has divided the sci‐
entific community and risks to ruin the good reputation of implant 
dentistry. Some of these disagreements are related to the inconsis‐
tency in the case definition, case selection, and the variability in di‐
agnostic thresholds for disease (Albrektsson, Chrcanovic, Ostman & 
Sennerby, 2017; Coli, Christiaens, Sennerby & Bruyn, 2017; Derks 
& Tomasi, 2015). Two recent systematic reviews indicated that ho‐
mogeneity in peri‐implantitis reporting is still lacking. Tomasi and 
Derks (2012) listed nine different threshold levels for radiographic 
bone loss applied to diagnose peri‐implantitis, and Ramanauskaite 
and Juodzbalys (2016) detected 10 case definitions for peri‐implan‐
titis. It is doubtful whether this is beneficial for the patient in the 
long run given the clinical treatment consequences that may follow, 
which could lead to unnecessary surgical treatment or even implant 
removal.
It is evident that patient‐related factors such as the inability to 
perform oral hygiene are related to peri‐implantitis (Serino & Strom, 
2009), and regular maintenance is key for prevention (de Souza et al., 
2013). This is confirmed by a meta‐analysis including 13 papers 
concluding that a more regular, individually tailored peri‐implant 
maintenance therapy prevents possible biologic complications over 
time and improves the long‐term outcome of implants (Monje et al., 
2016). Recent systematic reviews scrutinized additional patient‐re‐
lated factors and their association with implant treatment outcome. 
Among them, smoking habits have been shown to affect implant 
failure irrespective of implant surface, increase the risk of postop‐
erative infection, and yield more marginal bone loss especially in 
the maxilla (Chrcanovic, Albrektsson & Wennerberg, 2015). The his‐
tory of periodontal disease was suggested as a second important 
patient‐related factor. An increased susceptibility for periodontitis 
may translate into an increased susceptibility for implant loss, loss 
of supporting bone, and/or postoperative infection (Chrcanovic, 
Albrektsson & Wennerberg, 2014). No significant relation could 
be identified between diabetes and implant failure as no differ‐
ences were observed between patients with and without diabetes 
(Chrcanovic, Albrektsson & Wennerberg, 2014). As concluded in 
multiple articles, the difference in occlusal loading between imme‐
diate non‐functional and immediate functional loading may not af‐
fect the survival of these implants and no significant effect on the 
marginal bone loss has been reported (Chrcanovic, Albrektsson & 
Wennerberg, 2014). Furthermore, peri‐implant mucositis can also be 
induced by residual cement in the sulcus (Linkevicius et al., 2013) or 
be related to implant/prosthetic factors and lead to peri‐implanti‐
tis (Pesce et al., 2015). In a systematic review including 79 papers 
(Doornewaard et al., 2017), it was suggested that the implant fac‐
tor surface roughness had an impact on peri‐implant bone loss. The 
bone loss around the moderately rough and minimally rough surface 
implants was less than around rough surface implants. The addi‐
tional meta‐analysis confirmed that a history of periodontal disease 
and smoking leads to more peri‐implant bone loss.
1.1 | Definition of peri‐implant disease
Peri‐implant mucositis is defined by the 6th European Workshop 
of Periodontology as a reversible inflammation of the peri‐implant 
soft tissue with no signs of loss of the supporting bone. In the 7th 
European Workshop, it was diagnosed as bleeding on gentle prob‐
ing (Lang, Berglundh, & Working Group 4 of Seventh European 
Workshop on Periodontology, 2011). Peri‐implantitis is defined as 
inflammation of the soft tissues in combination with ongoing loss 
of the supporting peri‐implant bone beyond the physiological bone 
adaptation (Lindhe, Meyle, & Group D of European Workshop on 
Periodontology, 2008). The latter takes place as a consequence of 
biologic width establishment during initial healing. In the 3rd EAO 
consensus conference, it was stated that this initial bone remodeling 
may be unrelated to infection and is not necessarily peri‐implantitis 
(Klinge, Meyle & Working, 2012). It was therefore suggested that 
monitoring of implant performance should not be based on radio‐
graphs taken after implant placement but should relate to baseline 
recordings once tissue homeostasis has been established, in essence 
3 months after completion of the treatment (Klinge et al., 2012). 
Today, there is a general consensus that a baseline radiograph is re‐
quired for the assessment of bone changes over time (Lang, et al., 
2011). It is unfortunate that, this baseline radiograph is not always 
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available when clinicians assess the peri‐implant tissue condition. 
For these conditions, a pragmatic clinical approach for peri‐im‐
plantitis diagnosis was suggested by the 8th European Workshop 
for Periodontology (Sanz, Chapple, & Working Group 4 of the VIII 
European Workshop on Periodontology, 2012). The consensus re‐
port suggested a 2 mm additional loss beyond the “expected” bone 
level as a threshold in situations where baseline radiographic bone 
level assessment is lacking.
1.2 | Bone loss
Although the threshold for bone loss as a diagnostic criterion for dis‐
ease is not exactly specified in the previous EFP or EAO consensus 
meetings, there is agreement on the fact that stable crestal bone lev‐
els are most important for implant success because it is paramount 
for long‐term survival, esthetics, as well as peri‐implant health. 
Klinge et al. (2012) advised that critical bone loss ≥2 mm from the 
time of placement of the prosthetic device, in combination with 
bleeding on probing, should be interpreted as a “red flag” for the 
clinician to critically evaluate whether any intervention is indicated 
in the individual case and whether follow‐up and reassessment are 
required to confirm ongoing bone loss.
De Bruyn, Vandeweghe, Ruyffelaert, Cosyn and Sennerby 
(2013) reviewed radiographic assessment of modern implants and 
suggested that this mean bone loss assessment in patients with 
multiple implants yields very limited information on the condition of 
individual implants. However, it may be valid to benchmark implant 
systems. Given the fact that a majority of implants have very stable 
crestal bone levels over time and in a majority of cases sometimes 
no bone loss at all, the statistical interpretation of mean values often 
hides the condition of individual implants. It may be the reason why 
in the early studies, with mostly multiple implant cases for com‐
plete jaw rehabilitations, disease may have been overlooked. This 
is obvious from a radiographic follow‐up study of 640 patients with 
3,462 turned implants (Pikner, Grondahl, Jemt & Friberg, 2009). The 
mean bone loss after 5 years was 0.8 mm, and insignificant changes 
were reported in the years thereafter. However, the prevalence of 
implants with bone level located 3 mm apical to the implant–abut‐
ment junction was 2.8% at the time of prosthesis insertion but in‐
creased to 5.6%, 10.8%, 15.2%, 17.2%, and 23.5% after 1, 5, 10, 15, 
and 20 years, respectively. Vervaeke, Collaert, Cosyn and De Bruyn 
(2016) performed a prospective study, whereby 50 full‐arch reha‐
bilitations were immediately loaded the day of surgery on 5–8 im‐
plants in the maxilla and mandible and followed for 9 years. Implant 
survival was 99.2%, and the total mean bone loss, including initial 
remodeling, was calculated on patient level being limited to 1.7 mm. 
However, on implant level, 30% of the individual implants had lost 
more than 2 mm, figures largely affected by the inclusion of smok‐
ers and patients with a periodontal history. Hence, in the context 
of peri‐implantitis, the mean crestal bone values calculated on pa‐
tient level are not appropriate to detect disease around individual 
implants. The same holds true for cross‐sectional evaluation at a 
given time point when the baseline radiograph is lacking and bone 
levels are used as surrogate for peri‐implantitis detection. A recent 
report of Pettersson and Sennerby (2015) revealed that 15% of the 
implants showed more than 2 mm bone loss after 5 years. Applying 
the criteria of Sanz, et al. (2012), these implants could be diagnosed 
with peri‐implantitis. However, in this particular study, 25% of the 
implants had already bone loss up to 2 mm due to the specific im‐
plant design and over time there was stability or even improvement 
of the bone level.
1.3 | Probing depth
Periodontal probing is a common basic diagnostic tool in periodontal 
diagnosis around teeth. Ericsson and Lindhe (1993) had described 
distinct differences between teeth and implants in soft tissue com‐
position, organization, and attachment between the gingiva and the 
root surface on one hand and between the peri‐implant mucosa and 
the implant surface on the other. Therefore, this affects the interpre‐
tation of probing depth measurements. In healthy tissue, the probe 
penetration is more advanced around implants (Eickholz, Grotkamp, 
Steveling, Muhling & Staehle, 2001; Ericsson, 1986; Klinge, 1991) 
although this is depending on the probing force (Lang, Wetzel, 
Stich & Caffesse, 1994). Soft tissue around implants has also been 
found thicker than around teeth. This was first described in animals 
(Berglundh et al., 1991) and confirmed by human biopsies (Tomasi 
et al., 2014). Parpaiola et al. (2015) assessed the dimensions of the 
soft tissue cuff present at various aspects around teeth and implants 
using human biopsies. The soft tissue cuff that surrounded a tooth 
varied between 2 mm at flat surfaces and 4 mm at proximal surfaces, 
while at implant sites, the mucosa at proximal as well as flat sur‐
faces was 1–1.5 mm greater. The probing depth (PD) was greater at 
proximal than at facial or palatal/lingual surfaces at tooth sites and 
frequently also at implant sites. Furthermore, the PD and the soft 
tissue thickness were greater at implant than at adjacent tooth sites. 
Another study (Choquet et al., 2001) confirmed soft tissue thickness 
ranging between 0.85 mm and 6.85 mm and papilla heights of 7 mm 
to 9 mm under healthy conditions. Kan, Rungcharassaeng, Umezu 
and Kois (2003) measured an average interproximal thickness of the 
mucosa of 6 mm with a large range. Gallucci, Belser, Bernard and 
Magne (2004) found mesial and distal PD often ranging between 4 
and 8 mm depending on how scalloped the mucosa is. Animal stud‐
ies have shown that conditions of mild inflammation already yield 
deeper pockets around implants compared to teeth and this does 
not necessarily coincide with actual bone loss (Schou et al., 2002). A 
multilevel analysis performed in a group of 52 patients with screw‐
retained restorations on 92 implants revealed that deeper PD is as‐
sociated with higher tendency to bleed. This would indicate that an 
increase in PD in the absence of additional bone loss may be indica‐
tive of peri‐implant mucositis (Klinge, 1991). Also, Lang et al. (1994) 
concluded that the probe penetrates into the connective tissue in 
situations of mucositis. A few studies have looked for correlations 
between bone loss and clinical parameters among them probing. 
They concluded that probing depths are of limited value in predicting 
future peri‐implant bone loss (Dierens et al., 2012; Giannopoulou, 
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Bernard, Buser, Carrel & Belser, 2003; Weber, Crohin & Fiorellini, 
2000). Long‐term clinical studies have clearly shown that the prob‐
ing depth of healthy peri‐implant mucosa is not always smaller than 4 
mm but very often up to 6 mm (Dierens et al., 2012; Karoussis et al., 
2004; Lekholm et al., 1986). In an 18‐year follow‐up of single turned 
implants, pockets of up to 9 mm were found despite the absence of 
bone loss (Bergenblock et al., 2012). Also, Dierens et al. (2012) could 
not demonstrate correlations between PD and marginal bone lev‐
els around single implants functional for 16–22 years. Deep (>5 mm) 
and shallow (<4 mm) pockets were found in all bone level groups ex‐
plaining the poor predictive value of probing in the peri‐implantitis 
diagnosis when based on bone loss alone.
Probing is hindered by the location of the implant restoration es‐
pecially in case of partial or full jaw reconstructions. This may be the 
reason while in some studies patients with multiple implant cases are 
diagnosed more often with peri‐implantitis. Dalago, Schuldt Filho, 
Rodrigues, Renvert and Bianchini (2017) speculated that this could 
be attributed to less adequate oral hygiene or possible inclusion 
of more patients with periodontal history. Also, Serino and Strom 
(2009) proved that 65% of the implants with no good accessibility 
for oral hygiene showed peri‐implantitis compared to 18% when oral 
hygiene was feasible. It is obvious that incorrect probing may lead 
to iatrogenic bleeding. De Bruyn, Bouvry, et al. (2013) evaluated full 
jaw patients with implants placed in onlay grafts in the maxilla after 
a mean follow‐up of more than 9 years. To assess the peri‐implant 
health, they removed the screw‐retained reconstruction; 11% of 
the implants presented with a PD ≥ 5 mm despite more than 39% of 
the implants with BoP. There was no correlation between the reg‐
istered BoP 39% and the bone loss, but the PD reflected the bone 
loss. Serino, Turri and Lang (2013) demonstrated differences in PD 
with or without the implant construction in place. The PD showed 
a high correlation with bone loss when the reconstruction was re‐
moved. The presence of the construction impeded the accuracy of 
the PD registration, and only in 37% of the sites, similar results were 
obtained with probing with or without the construction. They con‐
cluded that PD reflects the bony defect only when access for probing 
is ideal. However, full jaw prosthesis often present with overhang, 
which may lead to inaccurate probing and false‐positive diagnosis. In 
addition, the measurement error encountered with probing is higher 
around implants than around teeth (Eickholz et al., 2001; Mombelli, 
Muhle, Bragger, Lang & Burgin, 1997), and the type of implant may 
affect the absolute PD value.
The aforementioned studies all suggest that the use of an abso‐
lute PD threshold to diagnose the soft tissue around implants should 
be performed with great caution. Based on the current evidence, 
the PD value alone cannot be considered a reliable indicator for de‐
fining peri‐implantitis (Serino et al., 2013). When actual bone loss is 
not correctly taken into account, due to the absence of a baseline 
radiograph, and when the PD is the only determining factor in the 
diagnosis, this may undoubtedly account for the high reported prev‐
alence of peri‐implantitis in some studies. It is obvious that change 
in PD over time, once a physiological steady state in the soft tissue 
has been established, may be regarded as an indicator of disease 
activity. Huang et al. (2013) suggested that a baseline PD should be 
established as a basis for comparison over time because initial im‐
plant location may affect the PD. A recent systematic review (Lee, 
Huang, Zhu & Weltman, 2017) concluded that the use of progres‐
sively deepening probing depth is more meaningful than using abso‐
lute PD values of ≥4 or 5 mm.
1.4 | Bleeding on probing
Bleeding on probing is used in periodontal diagnosis. It is a poor 
predictor of disease progression, but the absence of BoP is a good 
predictor of future tissue stability (Lang, Adler, Joss & Nyman, 
1990). Lekholm et al. (1986) reported that neither deep pockets nor 
BoP was found to be accompanied by accelerated marginal bone 
loss. The probability of a peri‐implant site to bleed upon probing 
is associated with PD, implant position and gender (Farina, Filippi, 
Brazzioli, Tomasi & Trombelli, 2017). Jepsen, Ruhling, Jepsen, 
Ohlenbusch and Albers (1996) found no difference in BoP between 
sites with progressive bone loss or stable sites. They pointed out 
that probing might also provoke a nonspecific bleeding that is un‐
related to the amount of inflammation and most probably related 
to the presence of the microgap between implants and abutments 
or reconstruction. Indeed, studies comparing teeth and implants, 
with respect to soft tissue healing, revealed that peri‐implant heal‐
ing as determined by crevicular molecular composition differs from 
periodontal healing. It is suggested that peri‐implant tissues rep‐
resent a higher pro‐inflammatory state (Emecen‐Huja et al., 2013). 
An analysis of 987 implants followed for 9–14 years demonstrates 
that signs of mucositis (BoP) are evenly distributed among implants 
with or without peri‐implantitis. There was actually no differ‐
ence in the proportion of implants with the absence or presence 
of bleeding/suppuration in relation to bone loss, bone gain, or 
bone stability (Roos‐Jansaker, Lindahl, Renvert & Renvert, 2006). 
Another large cohort study, including 4,591 implants from 2,060 
subjects, indicated that minimal bleeding did not correlate with 
bone loss but multipoint bleeding, profuse bleeding, or suppura‐
tion did (French, Cochran & Ofec, 2016). The use of a dichotomous 
diagnostic criterion (bleeding yes or no) is probably the reason why 
often high figures of mucositis are reported. Dierens et al. (2012) 
revealed 80% of BoP‐positive implants after 16–22 years of fol‐
low‐up despite a prevalence of peri‐implantitis as low as 5% and 
found no correlation between BoP and peri‐implantitis. Renvert, 
Lindahl and Persson (2018) evaluated 86 individuals at an examina‐
tion after 9–14 years and furthermore after 21–26 years of func‐
tion; 58% of the individuals with no bone loss during the interval 
had been diagnosed with mucositis during the first examination. 
On the other hand, nearly 22% of the patients without any sign of 
mucositis after 9–14 years had developed peri‐implantitis at a later 
stage. Data analysis failed to show that a diagnosis of mucositis 
after 9–14 years was predictive for development of peri‐implantitis 
after 21–26 years. This recent paper is in contradiction with the 
suggestion of Jepsen et al. (2015) that mucositis is a precursor for 
peri‐implantitis. This contradiction does not imply that one should 
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TA B L E  1   The number of papers and summarized relevant clinical information
Article 
number Author (year)
Study 
design
Treatment 
subgroups
Mean follow‐up 
years (range) Patients baseline
Implants 
baseline Survival % Implants for BL follow‐up
Time of 
baseline 
radiograph
Mean implant BL in 
mm (SD) Info on PPD
Mean 
PPD 
(mm) Bleeding index used Bleeding score %
Reported 
suppuration
Reported PI 
prevalence % on 
implant level
Definition of 
PI
1 Shi et al. (2018) R 10.1 (8–14.6) 67 98 96.6 95 1 1.19 (1.07) Mean 3.7 BoP 33.4 No 8.5 11
2a Sener‐Yamaner et al. 
(2017)
P 1: early 
loaded SLA
6.8 55 107 99.0 106 0 0.71 (0.35)     No 1.0 X
2b 2: early 
loaded 
SLA‐active
6.8 68 97.0 66 0.53 (0.28)     No 3.0
3 Galindo‐Moreno 
et al. (2017)
P  5 69 97 95.9 93 0 0.15 (0.95) 0.20 mm PPD 
reduction
 BoP 57.5 No 0.0  X
4a den Hartog et al. 
(2017)
P 1: smooth 
neck
5 31 31 96.2 26 0 1.26 (0.90) Mean 3.5 BoP 79.2 No 7.7 11
4b 2: rough 
neck
5 31 31 100 28 1.20 (1.10) Mean 3.3 BoP 59.3 No 14.2
4c 3: scalloped 
rough neck
5 31 31 96.2 26 2.28 (0.97) Mean 4.3 BoP 87.5 No 11.5
5 Froum and Khouly 
(2017)
R  8.5 52 52 100 28 0 0.30 (0.73) Mean 2.2 BoP 53.6 No 3.6  3
6a Ayna, Gulses and Acil 
(2018)
P 1: all‐on‐four 
mandible 
metal 
ceramic
7 16 64 100 60 0 0.74 (0.17) Mean 3.3 BoP 18.8 No 0.0 X
6b 2: all‐on‐four 
mandible 
bar 
retained
7 16 64 100 64 0.76 (0.15) Mean 3.6 BoP 32.8 No 0.0
7a Taschieri et al. (2017) R 1a: P‐PRP 
immediate 
loading
5 71 30 97.5 11 0 0.8 (0.35)     No 3.8  6
7b 1b: P‐PRP 
delayed 
loading
5 49 28 1.02 (0.27)     No
7c 2a: 
non‐P‐PRP 
immediate 
loading
5 38 11 97.9 9 0.6 (0.16)     No 10.4
7d 2b: 
non‐P‐PRP 
delayed 
loading
5 37 10 0.8 (0.89)     No
8 Cassetta et al. (2016) P  5 270 576 94.1 542 1 0.59 (1.34)     No 4.9  X
9 Ekfeldt et al. (2017) R  10.5 (10–11) 23 30 100 30 1 0.26 (0.60) 30% PPD > 4 
mm
 BoP 13.0 No 13.0 5 with cutoff 
bone loss of 
0.6 mm
10 Jensen et al. (2017) R  8 (3–16) 26 52 91.7 43 0 0.9 (1.0) Mean 3.3 mBI = 0.7 No 8.7 5 with cutoff 
bone loss of 
2mm
11 Tey et al. (2017) R  5.9 194 266 100 266 9 1.05 (1.07) Fd: 7.1% PPD ≥ 
6 mm
 BoP 95.0 No 7.1  3
12 Cosyn et al. (2016) P  5 22 22 95.0 17 0 0.19 (0.30) Mean 3.1 BoP 32.0 No 0.0  X
13 Glibert, De Bruyn 
and Ostman (2016)
P  6.2 (5.4–6.9) 40 112 99.1 111 0 0.35 (0.45)     No 0.9 11
14 Derks et al. (2016)a R  8.9 596 2367 97.0 1578 1 0.72 (1.15) 16.9% PPD ≥ 6 
mm
 BoP 60.9 No 24.9  15
15a Sanchez‐Siles et al. 
(2015)
R 1: smooth 
neck
6.44 171 515 100 515 9 1.12 (1.24)   Only for implants 
with PI
 Yes 2.9  5
15b 2: without 
smooth 
neck
5.61 229 729 100 729 2.51 (1.57)   Only for implants 
with PI
 Yes 14.4
16 Donati, Ekestubbe, 
Lindhe and 
Wennstrom (2016)
P  12 40 45 97.0 35 1 0.61 (2.10)   BoP 25.0 No 8.6  11
(Continues)
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(2018)
P 1: all‐on‐four 
mandible 
metal 
ceramic
7 16 64 100 60 0 0.74 (0.17) Mean 3.3 BoP 18.8 No 0.0 X
6b 2: all‐on‐four 
mandible 
bar 
retained
7 16 64 100 64 0.76 (0.15) Mean 3.6 BoP 32.8 No 0.0
7a Taschieri et al. (2017) R 1a: P‐PRP 
immediate 
loading
5 71 30 97.5 11 0 0.8 (0.35)     No 3.8  6
7b 1b: P‐PRP 
delayed 
loading
5 49 28 1.02 (0.27)     No
7c 2a: 
non‐P‐PRP 
immediate 
loading
5 38 11 97.9 9 0.6 (0.16)     No 10.4
7d 2b: 
non‐P‐PRP 
delayed 
loading
5 37 10 0.8 (0.89)     No
8 Cassetta et al. (2016) P  5 270 576 94.1 542 1 0.59 (1.34)     No 4.9  X
9 Ekfeldt et al. (2017) R  10.5 (10–11) 23 30 100 30 1 0.26 (0.60) 30% PPD > 4 
mm
 BoP 13.0 No 13.0 5 with cutoff 
bone loss of 
0.6 mm
10 Jensen et al. (2017) R  8 (3–16) 26 52 91.7 43 0 0.9 (1.0) Mean 3.3 mBI = 0.7 No 8.7 5 with cutoff 
bone loss of 
2mm
11 Tey et al. (2017) R  5.9 194 266 100 266 9 1.05 (1.07) Fd: 7.1% PPD ≥ 
6 mm
 BoP 95.0 No 7.1  3
12 Cosyn et al. (2016) P  5 22 22 95.0 17 0 0.19 (0.30) Mean 3.1 BoP 32.0 No 0.0  X
13 Glibert, De Bruyn 
and Ostman (2016)
P  6.2 (5.4–6.9) 40 112 99.1 111 0 0.35 (0.45)     No 0.9 11
14 Derks et al. (2016)a R  8.9 596 2367 97.0 1578 1 0.72 (1.15) 16.9% PPD ≥ 6 
mm
 BoP 60.9 No 24.9  15
15a Sanchez‐Siles et al. 
(2015)
R 1: smooth 
neck
6.44 171 515 100 515 9 1.12 (1.24)   Only for implants 
with PI
 Yes 2.9  5
15b 2: without 
smooth 
neck
5.61 229 729 100 729 2.51 (1.57)   Only for implants 
with PI
 Yes 14.4
16 Donati, Ekestubbe, 
Lindhe and 
Wennstrom (2016)
P  12 40 45 97.0 35 1 0.61 (2.10)   BoP 25.0 No 8.6  11
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Article 
number Author (year)
Study 
design
Treatment 
subgroups
Mean follow‐up 
years (range) Patients baseline
Implants 
baseline Survival % Implants for BL follow‐up
Time of 
baseline 
radiograph
Mean implant BL in 
mm (SD) Info on PPD
Mean 
PPD 
(mm) Bleeding index used Bleeding score %
Reported 
suppuration
Reported PI 
prevalence % on 
implant level
Definition of 
PI
17a Canullo et al. (2016) P 1: steam 
cleaning 
abutment
5 15 15 100 15 1 0.65 (0.36)   BoP 6.6 No 0.0 X
17b 2: plasma of 
argon 
cleaning 
abutment
5 15 15 100 15 0.21 (0.21)   BoP 20.0 No 0.0
18 Vandeweghe et al. 
(2016)
R  14.3 (10–21) 33 203 97.0 197 0 1.73 (1.54) Mean 3.6 BoP 47.2 No 4.1  3
19 Nedir, Nurdin, 
Vazquez, Abi Najm 
and Bischof (2016)
P  10 17 25 100 23 0 1.00 (0.90)     Yes 8.7  X
20 van Velzen et al. 
(2015)
P  10 250 506 99.7 367 0 1.21 (0.94) Mean 3.7 BoP 52.5 No 7.0  10
21 Trullenque‐Eriksson 
and Guisado‐Moya 
(2014)
R  13.19 (8.46–24.37) 105 342 90.6 342 1 1.84 (1.35)     No 1.7  13
22 Meijer et al. (2014) P  10 150 240 95.3 240 1 1.10 (1.10) Mean 3.4 mBI = 0.3 No 20.3  11
23 Schropp, Wenzel and 
Stavropoulos 
(2014)
P  10 63 63  47 0 0.67 (0.98) Fd: 36% PPD ≥ 
5 mm
 BoP 70.0 No 4.3  9
24 Mangano, Iaculli, 
Piattelli and 
Mangano (2015)
R  15.2 (10–20) 49 178 97.2 178 1 1.80 (0.60)     Yes 2.3  12
25 Simion, Gionso, 
Grossi, Briguglio 
and Fontana (2015)
R  12 29 59 93.2 59 1 1.34 (0.79) Mean 2.9 BoP 54.7 No 0.0  8
26 Meyle et al. (2014) P  10 20 54 96.3 54 1 0.60 (0.26) Mean 3.3 BoP 27.0 No 23.8  5
27 Anitua, Pinas, 
Begona and Orive 
(2014)
R  10.3 (7.2–11.4) 75 111 98.9 87 0 0.95 (0.65)     Yes 0.9  X
28 Donati et al. (2015) P  5 151 161 95.6 140 0 0.32 (1.15) Fd: 3.2% PPD ≥ 
6 mm
 BoP 13.0 No 2.9  11
29 Gelb, McAllister, 
Nummikoski and 
Del Fabbro (2013)
R  7.33 (7–8) 57 107 100 107 0 1.49 (1.03)   BoP 4.7  No 0.0  X
30 Chappuis et al. 
(2013)
R  20 67 95 89.5 85 0 0.14 (1.09) Mean 3.1 sBI = 0.1 Yes 20.0  X
31a Renvert et al. (2012) R 1: TiOblast 13 27 132  80 1 0.80 (–) Mean 2.6 BoP 82.1 Yes 32.1 Four with 
cutoff bone 
loss of 1mm31b 2: TiUnite 13 27 102  84 1.0 (–) Mean 3.1 BoP 89.7 Yes 39.1
32 Frisch et al. (2013) R  14.1 (10.2–18.9) 22 89 98.9 89 1 1.80 (1.50 Mean 3.1 BoP 21.0 No 8.0 1 with PPD ≥ 5 
mm and BoP
33 Lops et al. (2012) P  13.2 (10–21) 121 257 92.3 207 1 1.85 (1.55) Mean 2.2   No 8.7  X
34 Ormianer et al. 
(2012)
R  10 46 173 99.4 172 9 0.18 (–)     No 2.3  X
35a Ravald, Dahlgren, 
Teiwik and 
Grondahl (2013)
P 1: TiOblast 13.5 (12–15) 66 184 95.0 136 0 0.70 (–) Fd: 19% PPD ≥ 
6 mm upper 
jaw and 11% 
PPD ≥ 6 mm 
lower jaw
   Yes 6.0  X
35b 2: Machined 13.5 (12–15) 66 187 94.7 116 0.40 (–) Fd: 3% PPD ≥ 6 
mm upper jaw 
and 4% PPD ≥ 
6 mm lower 
jaw
   Yes 5.0
36 Ostman et al. (2012) P  10 46 121 99.2 106 0 0.70 (1.35)   BoP 9.2 Yes 1.9  4
37a Arnhart et al. (2013) R 1: TiUnite 6.7 (5.3–9.8) 47 136 98.5 136 1 1.53 (0.25) Mean 3.1 BoP 76.8 No 0.0  X
37b 2: Machined 8.2 (5.3–9.8) 52 96.2 52 2.42 (0.34) Mean 2.9 BoP 23.2 No 1.9
38 Lai et al. (2013) R  10 168 231 98.3 231 0 0.63 (0.68)     No 2.0  14
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5 15 15 100 15 0.21 (0.21)   BoP 20.0 No 0.0
18 Vandeweghe et al. 
(2016)
R  14.3 (10–21) 33 203 97.0 197 0 1.73 (1.54) Mean 3.6 BoP 47.2 No 4.1  3
19 Nedir, Nurdin, 
Vazquez, Abi Najm 
and Bischof (2016)
P  10 17 25 100 23 0 1.00 (0.90)     Yes 8.7  X
20 van Velzen et al. 
(2015)
P  10 250 506 99.7 367 0 1.21 (0.94) Mean 3.7 BoP 52.5 No 7.0  10
21 Trullenque‐Eriksson 
and Guisado‐Moya 
(2014)
R  13.19 (8.46–24.37) 105 342 90.6 342 1 1.84 (1.35)     No 1.7  13
22 Meijer et al. (2014) P  10 150 240 95.3 240 1 1.10 (1.10) Mean 3.4 mBI = 0.3 No 20.3  11
23 Schropp, Wenzel and 
Stavropoulos 
(2014)
P  10 63 63  47 0 0.67 (0.98) Fd: 36% PPD ≥ 
5 mm
 BoP 70.0 No 4.3  9
24 Mangano, Iaculli, 
Piattelli and 
Mangano (2015)
R  15.2 (10–20) 49 178 97.2 178 1 1.80 (0.60)     Yes 2.3  12
25 Simion, Gionso, 
Grossi, Briguglio 
and Fontana (2015)
R  12 29 59 93.2 59 1 1.34 (0.79) Mean 2.9 BoP 54.7 No 0.0  8
26 Meyle et al. (2014) P  10 20 54 96.3 54 1 0.60 (0.26) Mean 3.3 BoP 27.0 No 23.8  5
27 Anitua, Pinas, 
Begona and Orive 
(2014)
R  10.3 (7.2–11.4) 75 111 98.9 87 0 0.95 (0.65)     Yes 0.9  X
28 Donati et al. (2015) P  5 151 161 95.6 140 0 0.32 (1.15) Fd: 3.2% PPD ≥ 
6 mm
 BoP 13.0 No 2.9  11
29 Gelb, McAllister, 
Nummikoski and 
Del Fabbro (2013)
R  7.33 (7–8) 57 107 100 107 0 1.49 (1.03)   BoP 4.7  No 0.0  X
30 Chappuis et al. 
(2013)
R  20 67 95 89.5 85 0 0.14 (1.09) Mean 3.1 sBI = 0.1 Yes 20.0  X
31a Renvert et al. (2012) R 1: TiOblast 13 27 132  80 1 0.80 (–) Mean 2.6 BoP 82.1 Yes 32.1 Four with 
cutoff bone 
loss of 1mm31b 2: TiUnite 13 27 102  84 1.0 (–) Mean 3.1 BoP 89.7 Yes 39.1
32 Frisch et al. (2013) R  14.1 (10.2–18.9) 22 89 98.9 89 1 1.80 (1.50 Mean 3.1 BoP 21.0 No 8.0 1 with PPD ≥ 5 
mm and BoP
33 Lops et al. (2012) P  13.2 (10–21) 121 257 92.3 207 1 1.85 (1.55) Mean 2.2   No 8.7  X
34 Ormianer et al. 
(2012)
R  10 46 173 99.4 172 9 0.18 (–)     No 2.3  X
35a Ravald, Dahlgren, 
Teiwik and 
Grondahl (2013)
P 1: TiOblast 13.5 (12–15) 66 184 95.0 136 0 0.70 (–) Fd: 19% PPD ≥ 
6 mm upper 
jaw and 11% 
PPD ≥ 6 mm 
lower jaw
   Yes 6.0  X
35b 2: Machined 13.5 (12–15) 66 187 94.7 116 0.40 (–) Fd: 3% PPD ≥ 6 
mm upper jaw 
and 4% PPD ≥ 
6 mm lower 
jaw
   Yes 5.0
36 Ostman et al. (2012) P  10 46 121 99.2 106 0 0.70 (1.35)   BoP 9.2 Yes 1.9  4
37a Arnhart et al. (2013) R 1: TiUnite 6.7 (5.3–9.8) 47 136 98.5 136 1 1.53 (0.25) Mean 3.1 BoP 76.8 No 0.0  X
37b 2: Machined 8.2 (5.3–9.8) 52 96.2 52 2.42 (0.34) Mean 2.9 BoP 23.2 No 1.9
38 Lai et al. (2013) R  10 168 231 98.3 231 0 0.63 (0.68)     No 2.0  14
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become negligent and should not strive for the prevention of mu‐
cositis with good oral hygiene.
1.5 | Prevalence of peri‐implantitis
The prevalence of peri‐implant diseases significantly varies among 
clinical studies due to the inconsistent definitions, reporting meth‐
ods and study characteristics. One of the first publications on the 
prevalence of peri‐implant diseases by Zitzmann and Berglundh 
(2008) based on only two cross‐sectional studies reported 28–77% 
on patient level and 12–43% on implant sites with peri‐implantitis. 
Mombelli, Muller and Cionca (2012) calculated the prevalence of 
peri‐implantitis, based on 29 papers, in the order of 10% of the af‐
fected implants and 20% patients during 5–10 years after implant 
placement. Another review summarizing 10 papers reporting on 
the 10‐year clinical outcome with implants treated by sandblast‐
ing, grit blasting, acid‐etching, or combined treatments revealed 
that the survival was above 95% and <5% were diagnosed with pu‐
rulent infection or peri‐implantitis (Albrektsson, Buser & Sennerby, 
2012). A 10‐year follow‐up study including nearly 300 implants 
in 100 subjects revealed similar figures (Cecchinato, Parpaiola & 
Lindhe, 2014). They concluded that implant sites with radiographi‐
cally confirmed marginal bone loss of ≥1 mm were not common 
and that peri‐implantitis defined as bone loss >0.5 mm, BoP+, and 
PD ≥ 6 mm was detected in 12% of patients and only 5% of im‐
plants. Atieh, Alsabeeha, Faggion and Duncan (2013) performed 
a systematic review including information of 1,497 patient with 
6,283 implants and reported a respective prevalence of 18.8% on 
patient level and 9.6% on implant level. Derks and Tomasi (2015) 
performed a systematic review including 11 clinical studies and 
reported a broad range in the prevalence of peri‐implant mucosi‐
tis (19%–65%) and peri‐implantitis (1%–47%). The meta‐analyses 
estimated a weighted mean prevalence of peri‐implantitis affect‐
ing 22% of the implants. The meta‐regression showed a positive 
relationship between prevalence of peri‐implantitis and function 
time. This report was critically appraised by Jemt, Karouni, Abitbol, 
Zouiten and Antoun (2017) mentioning that the broad range in the 
prevalence could be attained to different thresholds for bone loss 
(range 0.4 mm–5 mm) used in the various case definition applied 
in the selected papers, in combination with a high dropout rate 
and the use of bone levels at a cross‐sectional time point instead 
of absolute bone loss. The systematic review of Lee et al. (2017) 
included 47 studies whereby the bone level thresholds for disease 
ranged from 1 to 5 mm and lead to a weighted mean implant‐based 
and subject‐based peri‐implantitis of 9.2% and 19.8%, respectively.
1.6 | Aim
The aim of this critical review was to describe whether the commonly 
used biologic diagnostic parameters correspond to long‐term outcome 
in terms of implant survival and reported peri‐implantitis prevalence.
2  | MATERIAL AND METHODS
2.1 | Search strategy
The focus of this study was on diagnostic aspects in relation to peri‐
implant health and clinical outcome in long‐term perspective. Given 
Article 
number Author (year)
Study 
design
Treatment 
subgroups
Mean follow‐up 
years (range) Patients baseline
Implants 
baseline Survival % Implants for BL follow‐up
Time of 
baseline 
radiograph
Mean implant BL in 
mm (SD) Info on PPD
Mean 
PPD 
(mm) Bleeding index used Bleeding score %
Reported 
suppuration
Reported PI 
prevalence % on 
implant level
Definition of 
PI
39 Levine, Sendi and 
Bornstein (2012)
P  5 20 21 100 21 0 0.58 (–)     No 0.0 X 
40a Rodrigo, Martin and 
Sanz (2012)
P 1: immediate 
placement
5 22 34  26 1 2.20 (0.90) Fd: 2.5% PPD ≥ 
5 mm
 BoP 14.2 No 8.8  7
40b 2: delayed 
placement
5 34  26 2.10 (1.00) Fd: 0% PPD ≥ 5 
mm
 BoP 13.7 No 2.9
41a Roccuzzo, Bonino, 
Aglietta and 
Dalmasso (2012)
P 1: 
periodon‐
tally 
healthy
10 112 61 96.6 59 0 0.75 (0.88) Mean 3.1 BoP 12.0 No 4.7  2
41b 2: 
moderately 
periodon‐
tally 
compro‐
mised
10 112 95 92.7 88 1.14 (1.11) Mean 3.5 BoP 31.0 No 11.2
41c 3: severely 
periodon‐
tally 
compro‐
mised
10 112 90 90.0 81 0.98 (1.22) Mean 3.9 BoP 30.9 No 15.1
BL, bone loss; PI, peri‐implantitis; IL, immediate loading; DL, delayed loading; IP, immediate placement; DP, delayed placement;  
R, retrospective; P, prospective; mBI, mean bleeding index; sBI, sulcus bleeding index; BoP, bleeding on probing; Fd, frequency distribution;  
PPD, probing pocket depth.
Time of baseline radiograph: 0 after surgery 1; variable time point after loading; 9 unknown.
aIn the Derks paper, only implants with bone loss data were extracted. Definition of peri‐implantitis: refer to Table 2.
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Mean 
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(mm) Bleeding index used Bleeding score %
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39 Levine, Sendi and 
Bornstein (2012)
P  5 20 21 100 21 0 0.58 (–)     No 0.0 X 
40a Rodrigo, Martin and 
Sanz (2012)
P 1: immediate 
placement
5 22 34  26 1 2.20 (0.90) Fd: 2.5% PPD ≥ 
5 mm
 BoP 14.2 No 8.8  7
40b 2: delayed 
placement
5 34  26 2.10 (1.00) Fd: 0% PPD ≥ 5 
mm
 BoP 13.7 No 2.9
41a Roccuzzo, Bonino, 
Aglietta and 
Dalmasso (2012)
P 1: 
periodon‐
tally 
healthy
10 112 61 96.6 59 0 0.75 (0.88) Mean 3.1 BoP 12.0 No 4.7  2
41b 2: 
moderately 
periodon‐
tally 
compro‐
mised
10 112 95 92.7 88 1.14 (1.11) Mean 3.5 BoP 31.0 No 11.2
41c 3: severely 
periodon‐
tally 
compro‐
mised
10 112 90 90.0 81 0.98 (1.22) Mean 3.9 BoP 30.9 No 15.1
BL, bone loss; PI, peri‐implantitis; IL, immediate loading; DL, delayed loading; IP, immediate placement; DP, delayed placement;  
R, retrospective; P, prospective; mBI, mean bleeding index; sBI, sulcus bleeding index; BoP, bleeding on probing; Fd, frequency distribution;  
PPD, probing pocket depth.
Time of baseline radiograph: 0 after surgery 1; variable time point after loading; 9 unknown.
aIn the Derks paper, only implants with bone loss data were extracted. Definition of peri‐implantitis: refer to Table 2.
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the overall consensus that progressive bone loss is the most impor‐
tant biologic parameter in the diagnosis of peri‐implantitis, it was 
decided to conduct a broad literature search using Pubmed data‐
base of the US National Library of Medicine for articles. Publications 
from 2011 up to September 2017 were selected using the general 
search algorithm: ((((((“bone loss”) OR “peri‐implantitis”)) OR “periim‐
plant”)) AND dental implant). Cross‐sectional reports were excluded 
because they report on bone levels and not on bone loss. The pa‐
pers had to be published in English, report on peri‐implantitis preva‐
lence together with mean bone loss on implant level (compared to 
a baseline measurement). No distinction was made based on study 
design (prospective or retrospective, RCT, or case series) or surgical 
or prosthetic treatment protocol as long as they included at least 10 
patients after a minimal mean follow‐up time of 5 years. Only studies 
discussing implant treatment in systemically healthy patients were 
included, but studies with smokers, patients with periodontal his‐
tory, controlled diabetes, or implants in sinus lifted bone were al‐
lowed. Studies describing implant treatment in tumor‐resected areas, 
studies involving extensive bone grafts or zygomatic or mini‐implant 
were excluded. An independent selection was performed based on 
the title and detailed information given in the abstract by two asses‐
sors (RD & HDB) who discussed jointly and reached a consensus in 
case of disagreement over the inclusion/exclusion of a paper.
2.2 | Data analysis
Papers were descriptively analyzed, and case definitions of peri‐im‐
plantitis were extracted. Analysis was performed on implant level. In 
the overall statistical analysis of implant survival and bone loss, the 
number of implants was used to weight the study or study groups 
throughout this review. A bivariate correlation analysis was per‐
formed using the Pearson r correlation coefficient. A correlation coef‐
ficient ranging from 0.01–0.19, 0.20–0.29, 0.30–0.39, 0.40–0.69, and 
above 0.70 represent a negligible, weak, moderate, strong, and very 
strong relationship, respectively. Correlation was calculated between 
the outcomes (i) reported prevalence of peri‐implantitis and (ii) mean 
implant survival, mean time in function, mean bone loss, mean PD, 
and mean BoP. Based on studies reporting on skewness and distribu‐
tions it could be expected that data, most commonly, are not normally 
distributed. This is caused by outliers, which could lead to large stand‐
ard deviations, rather caused by chance than population. Therefore, 
the standard deviations on population level are not used in weigh‐
ing of studies. The variability between studies is more reduced due 
to the lesser effect of outliers on the mean compared to the effect 
on the standard deviation and the amount of studies. Therefore, the 
Pearson correlation coefficients calculated, chosen as measure for 
a linear relationship between measures, are exploratory and could 
only be descriptively interpreted in conjunction with the graphical 
representations. If papers mentioned multiple case definitions, the 
one with the smallest bone loss threshold was applied in the correla‐
tion analysis. Papers with incomplete data reporting were not used 
for these analyses. In addition, the proportion of implants with bone 
loss above 1, 2, and 3 mm was estimated based on reported means 
and standard deviations. If the paper gave a frequency distribution 
for bone loss, the outcome of the frequency distribution was com‐
pared with the calculated proportion of implants with bone loss above 
2 mm. Descriptive statistics were performed using MatLab R2015b 
version (8.6.0.267246; The MathWorks, Inc., Natick, MA, USA).
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3  | RESULTS
3.1 | Selection and data reporting
The search yielded 4.173 papers whereof 255 publications were se‐
lected for full article reading. At last, 41 fulfilled the inclusion criteria, 
and the extracted data are summarized in Table 1. The peri‐implan‐
titis case definitions applied in the respective articles are illustrated 
in Table 2. In total, 41 articles, 21 prospective and 20 retrospec‐
tive, report on 56 treatment groups. They represent in total 4,198 
patients initially treated with 9,657 implants of various brands and 
with a variety of treatment protocols. A total of 6,246 implants were 
retrospectively analyzed, and 3,411 implants were prospectively 
analyzed. Table 3 shows the number of papers and their respective 
reported parameters.
3.2 | Survival rate and follow‐up time
Thirty‐eight of the 41 papers reported on survival rate in 49 treat‐
ment groups. The overall weighted mean survival rate was 96.9% 
[89.5%–100%] and 97.2% and 96.2% for retrospective and prospec‐
tive studies, respectively. In 39 and nine treatment groups, the re‐
ported implant survival rate was ranging between 95.0%–100% and 
90.0%–94.9%, respectively. Only one treatment group reported an 
implant survival below 90%. The weighted mean follow‐up time for 
the 56 treatment groups was 9.0 years with a range of 3–24.4 years. 
The weighted mean follow‐up was 9.2 (3–24.4) and 8.7 (5–21) years 
for retrospective and prospective groups, respectively. Thirty of 
the 56 treatment groups, representing initially 5886 implants, had a 
follow‐up time between 5 and 9.9 years with 4,894 implants at fol‐
low‐up (dropout 16.9%). In total, 24 treatment groups had a mean 
follow‐up time ranging between 10 and 14.9 years, with 3,498 im‐
plants at baseline and 3,025 implants at follow‐up (dropout 13.5%). 
Only two treatment groups had a mean follow‐up time of 15 years or 
longer, with 273 implants at baseline and 263 at follow‐up (dropout 
rate of 3.7%).
3.3 | Reported prevalence and case definition of 
peri‐implantitis
For all the included 56 treatment groups, the prevalence of peri‐
implantitis on implant level ranged between 0% and 39.7% as 
shown in Table 1 and was based on 15 different case definitions of 
peri‐implantitis. The case definitions varied considerably, mostly 
due to heterogeneous thresholds for bone loss and ranging from 
any detectable bone loss to 3.5 mm. Of the 41 papers, only 27 had 
a clearly defined threshold for bone loss, most commonly 2 mm. 
Some authors (Derks et al., 2015; Donati et al., 2015; Tey, Phillips 
& Tan, 2017) used more than one threshold and also gave more 
than one prevalence. Tey et al. (2017) made a distinction between 
clinical peri‐implant disease definitions according to Pjetursson 
et al. (2012) and the prevalence of peri‐implantitis based on ra‐
diographic diagnosis. Derks et al. (2015) used a combination of 
BoP and/or suppuration with a bone loss threshold of 0.5 mm 
and diagnosed 24.9% with peri‐implantitis. However, when they 
used a bone loss threshold of 2.0 mm, only 7.8% of the implants 
were diagnosed with peri‐implantitis. Also, Donati et al. (2015) 
used two different bone loss thresholds. Peri‐implantitis was di‐
agnosed in 2.9% or 5.7% of the implants when applying 2 or 1 mm 
thresholds for bone loss, respectively. The highest prevalence 
of peri‐implantitis (although coined incidence in the paper) was 
found in the study by Renvert, Lindahl and Rutger Persson (2012), 
originally reporting on 234 implants of two different brands after 
7 years of function in 54 patients. After 13 years, 164 implants 
were available for radiographic evaluation, which resulted in a 
dropout rate of 29.9% on implant level. The mean bone loss for 
the two study groups was 0.8 mm and 1.0 mm, respectively. Peri‐
implantitis was detected in nearly 40% of the implants based on 
a bone loss threshold above 1 mm following the first year after 
implant placement.
3.4 | Mean bone loss
The weighted overall mean bone loss as reported in the papers was 
1.1 mm (SD 1.0) and 1.3 mm (SD 1.1) and 0.9 mm (SD 1.0) for the 
retrospective and prospective studies, respectively. Time point of 
baseline radiographs was inconsistent. Baseline radiographs for 
bone loss calculation were taken immediately after implant place‐
ment in 22 papers, several months after the placement in 15 papers 
and three papers did not provide information about the time point. 
Figure 1 summarizes the mean bone loss in relation to the follow‐up 
time. With the reported mean and standard deviation, the estima‐
tion of the proportion of implants with cutoff bone loss above 1, 2, 
and 3 mm was calculated per treatment group and amounted to 51%, 
23%, and 8%, respectively (Figure 2).
3.5 | Mean peri‐implant probing depth and 
bleeding scores
In 25 papers, representing 34 treatment groups, the mean peri‐
implant probing depth was reported. The overall mean weighted 
PD was 3.3 mm; 75% of the treatment groups reported a mean PD 
between 3.0 and 3.9 mm and only one treatment group reported 
a mean PD above 4 mm, whereas the majority of papers reported 
the mean PD, four papers gave a detailed frequency distribu‐
tion as can be seen in Table 4. Twenty‐eight of the 41 included 
papers (38/56 treatment groups) reported mean bleeding scores 
around implants using various indices. Twenty‐four papers (34/56 
treatment groups) reported mean peri‐implant bleeding on prob‐
ing with a weighted mean of 52.2%, ranging from 4.7% to 95.0%. 
The BoP around implants was <25% for 13 treatment groups, 
ranging from 25% to 49.9% for eight treatment groups and rang‐
ing from 50% to 74.9% for six treatment groups. In seven treat‐
ment groups, a BoP ≥ 75% was reported. Two papers reported the 
modified bleeding index (Mombelli, van Oosten, Schurch & Land, 
1987): one the Sulcus bleeding (Muhlemann & Son, 1971) and one 
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gave only information about bleeding for implants diagnosed with 
peri‐implantitis.
3.6 | Suppuration
Eight papers (Table 5) reported that 0%–20% of the implants showed 
suppuration independently from BoP. In four papers, this percentage 
corresponds nicely with the reported prevalence of peri‐implantitis 
(~10%–40%), but in the other four papers, it did not. The high preva‐
lence of 20% in the paper of Chappuis et al. (2013) is explained by 
the inclusion of six previously lost implants as well as 13 successfully 
treated ones.
3.7 | Correlation between reported prevalence of 
peri‐implantitis and biologic parameters
Figures 3‒5 report the Pearson r correlation coefficient, visualize the 
correlation between the different biologic parameters, and reported 
prevalence of peri‐implantitis and follow‐up time. The dimension of 
the different bullets in the figures reflects the weight of the study.
Figure 3 visualizes mean bone loss versus the reported peri‐im‐
plantitis prevalence, the mean PD, and mean BoP quoted in the se‐
lected studies. The treatment group with the highest weight, being 
1,578 implants (Derks et al., 2016), reported a prevalence of 25% 
with a mean bone loss of 0.7 mm, 61% of the implants showing BoP, 
and 17% of the implants with a PPD ≥ 6 mm. The smallest treatment 
group included 15 implants (Canullo et al., 2016) and detected no 
peri‐implantitis with a limited mean bone loss (0.2 mm) and 20% 
of the implants showing BoP. Overall, the reported peri‐implanti‐
tis prevalence (Figure 3a) was in the majority of studies lower than 
10%. There was no distinct correlation between mean bone loss 
and peri‐implantitis prevalence. The range of mean bone loss up to 
2.5 mm may explain the large range in reported prevalence from 0% 
up to approximately 40%. The highest prevalence of nearly 40% 
was presented by Renvert et al. (2012), despite a mean bone loss of 
1 mm after an average 13 years of follow‐up. However, they defined 
peri‐implantitis using a threshold for bone loss of 1 mm. Arnhart 
et al. (2013) reported a prevalence of only 2% with a much higher 
mean bone loss of 2.4 mm, but they did not define a threshold for 
bone loss. In addition, data suggested the absence of a distinct rela‐
tionship between the biologic factors mean PD and mean BoP with 
mean bone loss. Some studies reported a high mean bone loss de‐
spite lower percentages of bleeding on probing. den Hartog, Meijer, 
Vissink and Raghoebar (2017) reported a mean bone loss of 2.3 mm 
after a follow‐up of 5‐year with a corresponding 87.5% BoP. Arnhart 
et al. (2013) gave a comparable mean bone loss of 2.4 mm after 8.2 
years with only 23.2% BoP. Tey et al. (2017) reported the highest 
mean BoP score of 95% with a mean bone loss of only 1 mm and 
7.1% of implants demonstrated peri‐implantitis. On the other hand, 
mean BoP showed a large range (4.7%–95%) irrespective of mean 
bone loss or mean PD (Figure 3c).
Figures 4a,b illustrate the lack of a relationship between the 
reported prevalence of peri‐implantitis and mean PD or mean BoP. 
Froum and Khouly (2017) reported the lowest mean PD (2.2 mm) 
and a corresponding reported prevalence of peri‐implantitis of 3.6%. 
den Hartog et al. (2017) reported the highest mean PPD (4.3 mm) 
and a reported prevalence of peri‐implantitis of 11.5%. Mean BoP 
showed a strong correlation with peri‐implantitis (Pearson r = 0.45). 
Tey et al. (2017) reported 95% BoP with only 7.1% of the implants 
demonstrating peri‐implantitis. Renvert et al. (2012) reported a sim‐
ilar 90% BoP with a mean PD of 3 mm but nevertheless 39% peri‐
implantitis. Another Swedish report (Ostman, Hellman & Sennerby, 
2012) came up with 9% of BoP and only 2% of peri‐implantitis, but 
PD values were missing.
Figure 5 visualizes the parameters survival rate, mean PD, and 
mean BoP in correlation with the mean function time. The survival 
rate shows negative strong correlation with the mean function time 
(Pearson r = −0.49). The correlation between mean PD and mean 
function time is weak (Pearson r = −0.27). There is no indication of 
correlation between the mean function time and mean BoP (Pearson 
r = −0.06).
4  | DISCUSSION
This review focused on reported peri‐implantitis prevalence and di‐
agnostic parameters considered important for long‐term outcome. 
Biologic complications often coined as peri‐implantitis may cause 
patient discomfort and may result in implant failure. For the current 
critical review, the search was limited from 2011 to September 2017, 
which coincides with the scientific debate on peri‐implantitis. It was 
decided to include all types of studies to be as inclusive as possi‐
ble. This may better reflect daily clinical practice when compared 
to well‐controlled academic studies. Because peri‐implantitis occurs 
commonly after longer function time, studies were included when at 
least 5 years of mean follow‐up was reported. Over the last decade, 
there has been a tremendous increase in the use of dental implants 
TA B L E  3   Number of papers and the respectively reported 
clinical parameters
Clinical Parameter Number of papers
Bone loss (BL) 41
Survival rate (SR) 38
Bleeding (B) 28
Probing pocket depth (PPD) 25
Suppuration (S) 8
Bone loss, survival rate and B + PPD + S 1
Bone loss, survival rate and two of the three 
parameters
21
Bone loss, survival rate and one of the three 
parameter
8
Bone loss and survival rate 8
Bone loss and B + PPD + S 1
Bone loss and two of the three parameters 2
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in daily clinical practice and consequently also scientific interest has 
increased. In 2011, twice as many papers appeared compared to 
2006 and from 2011 until 2017 as many papers appeared than in 
the previous 35 years as visualized in Figure 6. Despite 4,173 initially 
selected papers, only 255 were selected for full reading and only 41 
withstood the quality check. This is a disappointingly low proportion 
for a topic with such a significant impact for patients, clinicians, and 
implants industry.
The included material in this paper is strongly skewed toward 
retrospective studies, with 6,246 retrospective and 3,411 pro‐
spective analyzed implants. One could address that this leads to a 
higher inclusion of lower quality data. The high amount of retro‐
spective included implants is mainly caused by the large study of 
Derks et al. (2016) with 2,367 implants at baseline. However, the 
results showed a similar survival rate for retrospective and pro‐
spective analyzed implants, 97.2% and 96.2%, respectively, and 
in view of the large standard deviation, the difference in overall 
mean weighted bone loss between retrospective and prospec‐
tive studies is not conclusive. Due to the large heterogeneity in 
the definition of peri‐implantitis, it was not possible to calculate 
whether there was a difference in the reported peri‐implanti‐
tis prevalence between retrospective and prospective analyzed 
implants.
Regarding the statistical analysis, it was opted to use the Pearson 
correlation coefficient. Although the justification of this correlation 
coefficient instead of the Spearman’s relation coefficient could be 
a point of debate when data are possibly not normally distributed, 
the distribution at the level of the separate studies is most often 
skewed, when reported, and the presence of outliers cannot be 
excluded. This results in the distinct difference in variability of the 
different studies and the unreliability of estimates of the standard 
deviation for the individual studies. To circumvent the problem of 
unreliable estimates of the standard deviation, weighting by sample 
size was performed. At the level of the studies, though, no real out‐
liers are present. The Pearson correlation coefficient is a measure of 
linear approximation, and the Spearman correlation coefficient is a 
measure of association that is not immediately translates to linearity. 
In view of the attempt to demonstrate the absence or presence of 
linear relations, the Pearson correlation was chosen together with 
the graphical representation to visually assess the relation described 
by the coefficient. Testing of the correlation coefficient would have 
required normality at both levels and reliable estimates of the within 
variability and between study variability. It is clear that, these re‐
quirements were not met, and therefore, the presented results are 
exploratory and descriptive in nature.
The overall weighted mean implant survival in the selected 
studies was 96.9% based on remaining implants at the time of eval‐
uation. This shows that dental implant treatment today can be con‐
sidered predictable. Few papers report on implant failure caused 
by peri‐implantitis alone. In five treatment groups (Arnhart et al., 
2013; Cassetta, Driver, Brandetti & Calasso, 2016; Sener‐Yamaner, 
Yamaner, Sertgoz, Canakci & Ozcan, 2017), 5%, 1%, 3%, 0%, and 
2% of the implants were lost due to peri‐implantitis. Sener‐Yamaner 
et al. (2017) reported peri‐implantitis related failures after 5 years 
of loading especially in smokers. Arnhart et al. (2013) mentioned the 
loss of two implants after 5 and 10 years because of peri‐implantitis. 
The aforementioned three papers did not report prevalence of peri‐
implantitis for the remaining implants and were therefore excluded 
from the current review. Only two studies reported the prevalence 
F I G U R E  1   Mean bone loss (mm) in relation to the mean follow‐
up time (years) of the treatment groups; the size of the bullets 
reflects the number of implants reported in the treatment group
TA B L E  4   Frequency distribution op probing pocket depth (mm), between brackets percentage of implants with BoP. The article number 
refers to the reference provided in Table 1
Article 
number Author (year) Treatment groups
Percentage probing pocket depth (% implants BoP)
≤3 mm 3.1–4 mm 4.1–5 mm 5.1–6 mm >6 mm
11 Tey et al. (2017)  39.5 (89.5) 38.3 (99) 15.0 (95) 4.1 (100) 3.0 (100)
16 Donati et al. (2015)  80 16.8 3.2
35a Ravald et al. (2013) TiOblast upper jaw 49 32 19
TiOblast lower jaw 66 23 11
35b Machined upper jaw 47 50 3
Machined lower jaw 70 26 4
40a Rodrigo et al. (2012) Immediate 
placement
82.9 14.2 2.4 0.5
40b Delayed placement 81.1 15.6 2.4 0.9
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for peri‐implantitis of both lost and functioning implants. Lops et al. 
(2012) described eight of 257 (3.1%) implants with mobility due to 
severe peri‐implantitis and ten other implants were successfully 
treated during the 20‐year follow‐up period. Chappuis et al. (2013) 
reported 19 of 95 implants (20%) with peri‐implantitis whereof six 
implants were lost and 13 underwent a successful anti‐infectious 
therapy and were maintained with no further signs of acute infec‐
tion. Both studies included the treated peri‐implantitis implants in 
the reported prevalence figures despite successful treatment. In the 
other 36 papers, prevalence of peri‐implantitis was related to surviv‐
ing implants and dropouts or lost implants prior to the moment of 
assessment are not taken into account. One can conclude that infor‐
mation of peri‐implantitis in lost implants is scarce, and hence, the re‐
ported prevalence may be underestimated in the available literature.
In this review, the prevalence of peri‐implantitis on implant level 
ranged between 0% and 40%. The case definitions varied consid‐
erably between studies, mostly due to heterogeneous thresholds 
for bone loss, ranging from any detectable bone loss to 3.5 mm. 
This makes comparisons between studies difficult. Reflecting on 
the results presented in Table 6, it is obvious that reported preva‐
lence figures are larger when the threshold is low. Using the same 
implant design, Swedish studies that applied a threshold bone loss 
of approximately 0.5 mm concluded that 13%–25% of the implants 
were affected (Derks et al., 2016; Ekfeldt, Furst & Carlsson, 2017). 
Thresholds of bone loss of 2–3 mm yield much lower prevalence in 
the order of 5%–10%. However, the paper of Meijer, Raghoebar, de 
Waal and Vissink (2014) seems contradictory in this respect. With a 
2 mm threshold, they detected 20% despite a mean bone loss limited 
F I G U R E  2   Mean bone loss (mm) per treatment group and estimated proportion of implants with bone loss above 1, 2, and 3 mm. 
(green = retrospective study design; red = prospective study design) 
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to 1 mm. Their material consisted of IMZ and TPS implants from the 
first generation, known to be prone to bone loss over time. Meyle, 
Gersok, Boedeker and Gonzales (2014) reported a similarly high 
prevalence of 24% but a low mean bone loss of 0.60 mm also after 
10 years. The threshold of bone loss for the diagnosis for peri‐im‐
plantitis was any bone loss and this could explain the high reported 
prevalence. If one were to apply the guidelines of the 8th European 
Workshop on Periodontology on their material, the prevalence would 
not be 23.8% but 0%. Also, Renvert et al. (2012) reported peri‐im‐
plantitis prevalence of 32.1% and 39.7% for both treatment groups, 
respectively. The implants evaluated after 13 years showed a mean 
bone loss of 0.8 mm for TiOblast surfaces and 1.0 mm for TiUnite 
surfaces of peri‐implantitis in both treatment groups. Despite this 
low mean bone loss, high bleedings scores around the implants of 
82% and 90% were reported.
A serious problem in this review is the heterogeneity of the 
data and the variation of the follow‐up time within each study. This 
was recognized by previous authors (Frisch, Ziebolz & Rinke, 2013; 
Trullenque‐Eriksson & Guisado‐Moya, 2014) and obvious from the 
study of Jensen, Meijer, Raghoebar, Kerdijk and Cune (2017). The 
latter had a mean follow‐up time of 8 years based on implants in 
function from 3 years up to 16 years of follow‐up. One could debate 
whether it is appropriate to sample implants with a large range in 
function time as being one group or whether cohort analysis based 
on function periods would be more justified.
Bone loss is in most of the studies expressed as a mean value 
with a standard deviation, which may hide outliers in the analysis. 
When reporting mean values of bone loss in a study population, it 
implies that the data are normally distributed. If this were the case, 
the mean and standard deviation would suffice to estimate the per‐
centage of implants with a defined bone loss. Doornewaard et al. 
(2017) applied this in a systematic review and calculated the pro‐
portion of implants with bone loss over 1, 2 and 3 mm, respectively. 
The same approach was applied as a post hoc analysis using the 13 
papers that reported both the mean and standard deviation and also 
TA B L E  5   Suppurating implants (%) in relation to the reported peri‐implantitis prevalence. The article number refers to the reference 
provided in Table 1
Article number Author (year) Treatment group
Suppurating implants/total 
number (%)
Reported PI prevalence on 
implant level (%)
15 Sanchez‐Siles et al. 
(2015)
2/1244 (0.2) 9.6
19 Nedir et al. (2016) 0/25 (0.0) 8.7
24 Mangano et al. (2015) 4/178 (2.2) 2.3
27 Anitua et al. (2014) 1/111 (0.9) 0.9
30 Chappuis et al. (2013) 19/95 (20) 20.0
31a Renvert et al. (2012) 1: TiOblast (1.2) 32.1
31b 2: TiUnite (3.8) 39.1
35a Ravald et al. (2013) 1: TiOblast 2/136 (1.5) 6.0
35b 2: Machined 2/116 (1.7) 5.0
36 Ostman et al. (2012) 2/106 (1.9) 1.9
F I G U R E  3   (a) Mean bone loss (mm) in relation to the reported 
prevalence of peri‐implantitis (%); r = −0.07 (negligible correlation). 
(b) Mean bone loss (mm) in relation to probing pocket depth (mm); 
r = −0.15 (negligible correlation). (C) Mean bone loss (mm) in relation 
to bleeding on probing (%): r = −0.06 (negligible correlation); the 
size of the bullets reflects the number of implants reported in the 
treatment group; the number in the bullets refers to the article 
number provided in Table 1
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gave a frequency distribution of bone loss as presented in Table 6. 
We observed that the calculated proportion of implants with bone 
loss was an overestimation when compared to the frequency dis‐
tribution reported. Hence, bone loss is probably not normally dis‐
tributed within the study population but positively skewed. Hence, 
nonparametric statistics is appropriate including statistical parame‐
ters median, interquartile ranges as well as frequency distributions. 
This could refine the pre valence figures in scientific reports. Only 
four of the 13 previously mentioned papers reported their data in 
this proposed way (Donati et al., 2015; Ekfeldt et al., 2017; Frisch 
et al., 2013; van Velzen, Ofec, Schulten & Ten Bruggenkate, 2015) 
and all reported lower medians than means. This may suggest that 
few implants with an extensive bone loss have a big impact on the 
mean and the standard deviation. This is confirmed by Donati et al. 
(2015) who detected three of the 35 evaluated implants with bone 
loss of 5, 7, and 9 mm. They reported a median of 0.2 mm and an 
interquartile range of −0.7 to 0.5 mm. Ekfeldt et al. (2017) showed 
comparable results where only two of the 30 evaluated implants 
lost, respectively, 1.8 mm and 2.4 mm bone. This resulted in a higher 
mean bone loss of 0.26 mm compared to a median of 0.0 mm. It is 
obvious that the methodology applied in our review yielded over‐
estimated proportions of implants with a certain threshold of bone 
loss.
The pooled data from this review did not demonstrate a rela‐
tionship between mean function time and mean implant survival 
or peri‐implantitis prevalence. This could be partially explained by 
dropouts of implants that are not further assessed during follow‐up. 
This review contains four papers that reported the Kaplan–Meier 
survival analysis. Chappuis et al. (2013) reported a sudden increase 
after 12 years, the latter related to a combination of biologic and 
technical failures. Jensen et al. (2017) analyzed the implants ret‐
rospectively with a start of the measurement after 3 years and re‐
ported all losses before 5 years. Also, the other two papers showed 
F I G U R E  4   (a) Reported prevalence of peri‐implantitis (%) in 
relation to mean probing pocket depth (mm): r = −0.11 (negligible 
correlation). (b) Reported prevalence of peri‐implantitis (%) in 
relation to bleeding on probing (%): r = 0.45 (strong correlation); 
the size of the bullets reflects the number of implants reported in 
the treatment group; the number in the bullets refers to the article 
number provided in Table 1
F I G U R E  5   (a) Mean follow‐up time (years) in relation to survival 
rate (%): r = 0.49 (strong correlation). (b) Mean follow‐up time 
(years) in relation to probing pocket depth (mm): r = −0.27 (weak 
correlation). (c) Mean follow‐up time (years) in relation to bleeding 
on probing (%): r = −0.06 (negligible correlation); the size of the 
bullets reflects the number of implants reported in the treatment 
group
F I G U R E  6   Number of publications per year from the search 
string applied in this systematic review
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a downhill Kaplan–Meier survival rate in relation to follow‐up time 
(Meyle et al., 2014; Shi et al., 2018). It seems therefore appropriate to 
conclude that implants do fail over time, although in small numbers.
The mean PD reported in 25 of the 41 papers varied between 
2.2 mm and 4.3 mm, with only one study reporting a mean PD above 
4 mm. It is obvious from the results presented in this review that a re‐
lationship between mean PD and mean bone loss or peri‐implantitis 
prevalence is absent. From a clinical perspective, one should realize 
that probing is technique sensitive and may be affected by probing 
force, probing direction, design of the restorations and design of im‐
plant, and type of prosthetic components. Obviously, the prosthetic 
reconstruction may jeopardize probing due to incorrect probing di‐
rection or restorations’ overhangs. This may potentially also provoke 
iatrogenic bleeding. Serino et al. (2013) examined the PD before and 
after removal of the prosthetic reconstruction. While the PD before 
removal had a poor correlation with bone loss, it correlated well 
with the PD after removal as assessed during surgery. Christiaens 
et al. (2017) concluded that probing depth around peri‐implantitis 
affected implants significantly underestimated the true bone level 
by 1 mm. Garcia‐Garcia, Mir‐Mari, Benic, Figueiredo and Valmaseda‐
Castellon (2016) showed a significant underestimation of the inter‐
proximal bone level by intra‐oral radiography of 1.3 mm on average. 
Merli et al. (2014) concluded that assessment of bone loss by three 
clinicians showed the highest intraclass correlation coefficient while 
the intraclass correlation coefficient for PD and BoP was low. The 
paper of Coli et al. (2017) concluded, based on evidence from animal 
as well as human studies, that it is unreliable to simply diagnose an 
implant as having peri‐implantitis because of a pre‐established PD. It 
is well known that values of 6–9 mm PD have been described in as‐
sociation with long‐term successful dental implants. Human studies 
have shown that in healthy peri‐implant mucosa, the probing depths 
are in most of the cases (60%–63%) above 4 mm and even up to 
6 mm (Bergenblock et al., 2012; Lekholm et al., 1986). One should 
also keep in mind that the interproximal probing depth measurement 
is affected by a significant papilla regrowth after crown installation. 
These findings support the importance of a combination of diagnos‐
tic parameters when diagnosing peri‐implantitis.
This critical review revealed mean BoP ranging from 4.7%–95%. 
Gerber, Tan, Balmer, Salvi and Lang (2009) concluded that BoP is 
highly dependent on the probing pressure, which strengthens the 
difficulty of interpreting probing assessments. When the probing 
pressure increased from 0.15N to 0.25N, BoP increased with 14% 
at implant sites. This increase was found to be significantly higher 
when compared to tooth sites (6.6%). A low probing force of 0.15N 
resulted in similar findings at implants and tooth sites. None of the 
selected papers gave detailed information on probing force. Only 
the paper by Chappuis et al. (2013) used the sulcus bleeding index 
instead of BoP. By doing so, there is no de‐attachment of the mucosa 
around the implant as it is carried out without using a high force. This 
could explain the low bleeding score.
Merli et al. (2017) evaluated the peri‐implant BoP together with 
PD scoring. They observed a 39% BoP and an increase in odds ratio by 
1.8 for each 1 mm increment of PD. For pockets of 3 mm, 30%–40% 
were BoP‐positive. Over 80% of the pockets of 7 mm were bleeding. 
Also, Farina et al. (2017) confirmed an odds ratio for BoP of 1.6 for 
each 1 mm increment of PD. In both studies, also similar propor‐
tion of BoP‐positive sites was detected for pockets of 4 mm (27%) 
and 7 mm (60%). It is therefore obvious that deeper pockets have a 
higher tendency to bleed. A recent large retrospective cohort study 
(French et al., 2016) of nearly 5,000 Straumann implants placed in 
2,060 patients with up to 10‐year follow‐up concluded that time 
alone and minimal bleeding did not correlate with bone loss but that 
care should be taken for implants with profuse bleeding or suppura‐
tion. They found the highest mean bone loss around implants with 
suppuration and minor changes for implants with minimal to moder‐
ate or profuse bleeding. They concluded that BoP around implants is 
a weak indicator of ongoing or future loss of crestal bone. The fact 
that BoP is a binary analysis of bleeding (bleeding or no bleeding) 
may possibly explain high false‐positive bleeding scores. They sug‐
gested the use of an ordinal scale assessment to overcome this issue. 
In our review, only three of the 41 included papers used an ordinal 
scale, which may explain why the review could not find a significant 
correlation between reported prevalence and mean BoP and mean 
bone loss.
Suppuration is an unequivocal sign of inflammation that may 
be indicative of bone loss. In most clinical papers, suppuration 
as a diagnostic parameter is grouped together with bleeding and 
denoted as “BoP and/or suppuration.” Only eight of 41 selected 
papers gave information about suppuration separately. Sanchez‐
Siles, Munoz‐Camara, Salazar‐Sanchez, Ballester‐Ferrandis and 
Camacho‐Alonso (2015) reported only two suppurating implants 
of the 120 implants diagnosed with peri‐implantitis. On the other 
hand, in four other papers, the prevalence of suppurating implants 
strongly correlated with the reported prevalence. This latter find‐
ing is in accordance with the results of the study of French et al. 
(2016). They specified that suppuration was detected in implants 
with the highest bone loss and suggested it could be useful for 
clinical diagnosis. Confirmation in more studies seems essential to 
confirm this assumption.
5  | CONCLUSIONS
There is a large variation in the peri‐implantitis case definitions, and 
reporting of biologic parameters is incomplete. Peri‐implantitis prev‐
alence did not correlate with diagnostic parameters mean PD, mean 
BoP, and mean bone loss. Only mean BoP correlated strong, with 
reported prevalence of peri‐implantitis. Survival rate showed a sub‐
stantial correlation with function time, with minor implant loss over 
time. Inconsistent reporting of peri‐implantitis prevalence needs to 
be addressed, and an unambiguous case definition for peri‐implan‐
titis is of utmost importance for science as well as clinical practice.
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